MACK

Merrimack Pharmaceuticals, Inc.

Investor Moves

Name	Value	Action	Change	Price	Current Price
BlackRockInvestor $-10.7M ExitQ2 2024 $11M -- --
Ken GriffinCitadel Advisors $-810.0K ExitQ2 2024 $810k -- --
Jim SimonsRenaissance Technologies $-2.4K ExitQ2 2024 $2.4k -- --
Jim SimonsRenaissance Technologies $-2.4K ExitQ2 2024 $2.4k -- --

News

newsfilecorp.comMackay Gold & Silver Announces Listing on the OTCQB Under the Symbol "MKGSF"newsfilecorp.comMay 22

About Merrimack Pharmaceuticals, Inc.

Founded in 1993, Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts.

CEO: Gary L. Crocker
IPO Date: Mar 29, 2012

Market Data

Open: $15.15
High: $15.17
Low: $15.14
Volume: 922.5K
Avg Volume: 195.5K
52W High: $15.89
52W Low: $11.53

Valuation

Market Cap: $224M
Enterprise Value: $218M
Dividend Yield: 15.1%

Financials

Free Cash Flow: $-1.5M
Revenue: $0
Net Income: $-1.2M
Cash: $6.0M
Debt: $0

Events

DividendMay 20

$15.1

MACK smart money exposure | 交易笔记